We are live on ! Find out more
MA

Montag & Associates Portfolio holdings

AUM $2.37B
1-Year Est. Return 28.86%
This Fund
S&P 500
This Quarter Est. Return
-12.61%
1 Year Est. Return
+28.86%
3 Year Est. Return
+82.88%
5 Year Est. Return
+98.91%
10 Year Est. Return
+378.43%
AUM
$1.55B
AUM Growth
-$338M
Cap. Flow
-$81.1M
Cap. Flow %
-5.25%
Top 10 Hldgs %
30.28%
Holding
871
New
14
Increased
114
Reduced
237
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 12.78%
2 Healthcare 9.97%
3 Financials 9.37%
4 Consumer Discretionary 7.32%
5 Consumer Staples 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOE icon
401
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$146K 0.01%
1,130
EZM icon
402
WisdomTree US MidCap Fund
EZM
$950M
$142K 0.01%
3,097
+12
+0.4% +$608
RPG icon
403
Invesco S&P 500 Pure Growth ETF
RPG
$2.07B
$140K 0.01%
4,750
ESGR
404
DELISTED
Enstar Group
ESGR
$139K 0.01%
648
-2
-0.3% -$465
PPL
405
PPL Corp
PPL
$26B
$139K 0.01%
5,100
+100
+2% +$2.87K
TCPC icon
406
BlackRock TCP Capital
TCPC
$327M
$138K 0.01%
11,000
TMUS icon
407
T-Mobile US
TMUS
$193B
$135K 0.01%
1,000
IJK icon
408
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
$134K 0.01%
2,100
YUMC icon
409
Yum China
YUMC
$16.5B
$134K 0.01%
2,771
COLM icon
410
Columbia Sportswear
COLM
$2.93B
$133K 0.01%
1,852
-2
-0.1% -$160
ALLE icon
411
Allegion
ALLE
$14.3B
$132K 0.01%
1,348
-2
-0.1% -$217
C icon
412
Citigroup
C
$224B
$132K 0.01%
2,864
BWA icon
413
BorgWarner
BWA
$13.5B
$130K 0.01%
4,430
-4,658
-51% -$153K
Y
414
DELISTED
Alleghany Corp
Y
$130K 0.01%
156
-2,300
-94% -$1.92M
AMRX icon
415
Amneal Pharmaceuticals
AMRX
$5.77B
$127K 0.01%
40,000
OKE icon
416
Oneok
OKE
$55.4B
$127K 0.01%
2,293
DGX icon
417
Quest Diagnostics
DGX
$26.3B
$126K 0.01%
950
RCM
418
DELISTED
R1 RCM Inc. Common Stock
RCM
$126K 0.01%
6,000
BHVN
419
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$126K 0.01%
863
CHKP icon
420
Check Point Software Technologies
CHKP
$12.8B
$120K 0.01%
989
RWT
421
Redwood Trust
RWT
$573M
$118K 0.01%
15,300
-30,000
-66% -$276K
NUV icon
422
Nuveen Municipal Value Fund
NUV
$1.9B
$116K 0.01%
13,000
EHC icon
423
Encompass Health
EHC
$12.4B
$112K 0.01%
2,514
GBDC icon
424
Golub Capital BDC
GBDC
$3.39B
$110K 0.01%
8,500
+2,000
+31% +$28.6K
TXRH icon
425
Texas Roadhouse
TXRH
$13.7B
$110K 0.01%
1,500

Similar funds

Montag & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Montag & Associates held 871 positions worth $1.55B, down 18% from $1.88B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Montag & Associates withdrew a net $81.1M in Q2 2022, closing 19 positions and reducing 237 holdings. Its most notable exit was Amedisys, an estimated $2.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Montag & Associates opened a new position in iShares iBonds Dec 2023 Term Treasury ETF worth $1.76M.

  • Montag & Associates's largest Q2 2022 buy was iShares iBonds Dec 2023 Term Treasury ETF: 70,553 shares worth $1.76M.
  • Montag & Associates added most to JPMorgan Ultra-Short Income ETF in Q2 2022, an estimated $13.1M increase.
  • Montag & Associates's biggest Q2 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $19M.
  • Montag & Associates fully exited Amedisys in Q2 2022, selling an estimated $2.86M.
  • Montag & Associates's ten largest holdings make up 30% of its $1.55B portfolio in Q2 2022.
  • Montag & Associates opened 14 new positions and closed 19 in Q2 2022.
  • Montag & Associates's portfolio value fell 18% quarter-over-quarter to $1.55B.

Based on Montag & Associates's 13F filing for Q2 2022, filed 10 Aug 2022.